1. Home
  2. CFFN vs GHRS Comparison

CFFN vs GHRS Comparison

Compare CFFN & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capitol Federal Financial Inc.

CFFN

Capitol Federal Financial Inc.

HOLD

Current Price

$7.63

Market Cap

981.1M

Sector

Finance

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$22.02

Market Cap

947.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFFN
GHRS
Founded
1893
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
981.1M
947.2M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
CFFN
GHRS
Price
$7.63
$22.02
Analyst Decision
Hold
Strong Buy
Analyst Count
2
8
Target Price
$7.25
$41.38
AVG Volume (30 Days)
830.8K
262.5K
Earning Date
04-29-2026
05-01-2026
Dividend Yield
4.51%
N/A
EPS Growth
79.31
N/A
EPS
0.32
N/A
Revenue
$16,300,000.00
N/A
Revenue This Year
$20.16
N/A
Revenue Next Year
$6.62
N/A
P/E Ratio
$23.78
N/A
Revenue Growth
6.54
N/A
52 Week Low
$5.51
$10.67
52 Week High
$7.97
$24.66

Technical Indicators

Market Signals
Indicator
CFFN
GHRS
Relative Strength Index (RSI) 49.94 62.47
Support Level $7.47 $12.41
Resistance Level $7.85 $22.88
Average True Range (ATR) 0.14 1.42
MACD -0.04 -0.11
Stochastic Oscillator 36.78 65.19

Price Performance

Historical Comparison
CFFN
GHRS

About CFFN Capitol Federal Financial Inc.

Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It mainly serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: